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Abstract
Fibrinogen is fundamental to hemostasis and falls
rapidly in trauma hemorrhage, although levels are not
routinely measured in the acute bleeding episode.
Prompt identification of critically low levels of
fibrinogen and early supplementation has the
potential to correct trauma-induced coagulation and
improve outcomes. Early estimation of
hypofibrinogenemia is possible using surrogate
markers of shock and hemorrhage; for example,
hemoglobin and base excess. Rapid replacement with
fibrinogen concentrate or cryoprecipitate should be
considered a clinical priority in major trauma
hemorrhage.
Fibrinogen is the primary substrate of the coagulation
system and is fundamental to hemostasis. Fibrinogen
falls to critical levels soon after the onset of major
trauma hemorrhage but is not considered part of rou-
tine clotting assays. To maintain the integrity of co-
agulation function it is recommended that fibrinogen
is replaced when it falls below 150 to 200 mg/dl.
Early recognition and replacement has the potential
to rapidly reverse trauma-induced coagulopathy, arrest
hemorrhage and improve outcomes. Schlimp and col-
leagues have demonstrated that it is possible to esti-
mate fibrinogen in the emergency department using
widely available point-of-care assays [1].
The literature contains numerous reports of improved
outcomes when early high-dose plasma is administered as
part of a massive hemorrhage protocol. Fibrinogen supple-
mentation with either cryoprecipitate (the UK or USA) or
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fibrinogen concentrate (Europe) is often delayed or consid-
ered second line in the empiric delivery of hemostatic co-
agulation therapy. The therapeutic mechanism by which
plasma controls hemorrhage or corrects coagulopathy re-
mains unknown. Early fibrinogen supplementation is com-
monplace in postpartum hemorrhage and cardiac surgery,
with only limited data indicating a potential therapeutic
benefit in trauma [2]. Each unit of plasma contains approxi-
mately 500 mg fibrinogen, and therefore the efficacy of
large-volume plasma transfusions in massive hemorrhage
protocols may in part be due to restoration of fibrinogen
levels. For this reason, early fibrinogen replacement is the
subject of two pilot randomized controlled trials in the UK
(CRYOSTAT) [3] and Austria (FiTIC) [4] due to report
later this year.
Fibrinogen falls early [5], rapidly reaches critical threshold
values relative to other coagulation factors [6] and is associ-
ated with higher transfusion requirements and increased
mortality. Schlimp and colleagues have confirmed that
hypofibrinogenemia is common in major trauma and is an
almost universal problem in those patients presenting with
hemoglobin <8 g/dl [1]. The identification of early
hypofibrinogenemia requires a laboratory assay; for ex-
ample, the Clauss method. Fibrinogen levels are rarely
available to the trauma physician in a clinically relevant
timeframe and thus fibrinogen supplementation (for ex-
ample, cryoprecipitate) is often delayed.
Rotational thromboelastometry and thromboelastography
provide a more rapid and global assessment of coagulation
and can provide an estimate of the contribution of func-
tional fibrinogen to clot strength [7]. These tests are expen-
sive, however, and although available at point of care they
require further modification, simplification and validation
before this technology has global appeal for the trauma
community. This study has shown it is possible to risk
stratify patients for low or critical fibrinogen levels, using
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hemoglobin and base excess that are rapidly available in
emergency trauma care. However, even with the addition of
the Injury Severity Score, which is not available within the
first few hours of care, the regression model only accounted
for 51% of the variation in fibrinogen. Other important, iat-
rogenic and patient factors therefore contribute signifi-
cantly to the depletion of fibrinogen in trauma hemorrhage.
The mechanism by which fibrinogen loss occurs in
trauma continues to be the subject of ongoing debate
and research. There is limited evidence to support a
consumptive process such as disseminated intravascular
coagulation [8,9], although clearly fibrinogen will be uti-
lized because the coagulation system is activated follow-
ing hemorrhage. Acidosis and hypothermia compound
trauma-induced coagulopathy and have profound effects
on fibrinogen breakdown and synthesis [10], which is
supported by the findings of the current study that dem-
onstrated critical and low levels of fibrinogen in 81% and
63% of shocked patients, respectively [1]. Finally, resusci-
tation with gelatins and hydroxyethyl starch solution re-
duce the concentration of fibrinogen through dilution
and interfere with fibrin polymerization [11]. Fibrinogen
is thought to only contribute approximately one-third of
viscoelastic strength to the overall clot, with platelets be-
ing the major determinant of clot firmness in rotational
thromboelastometry/thromboelastography . Estimation
of fibrinogen deficit alone risks missing the global de-
rangement of hemostasis typified by trauma-induced
coagulopathy.
The estimation of fibrinogen levels by Schlimp and col-
leagues reminds us that fibrinogen loss is not only rapid
and significant in trauma but is detectable in the emergency
department. Metabolic acidosis, injury severity and
hemorrhage reduce fibrinogen, but other endogenous and
iatrogenic factors contribute to the depletion of this pri-
mary substrate of coagulation. Rapid identification of
hypofibrinogenemia should be routine in all injured pa-
tients and a priority in major trauma hemorrhage, either
through estimation or functional assessment with rotational
thromboelastometry/thromboelastography. Understanding
the mechanism by which fibrinogen is lost and the efficacy
of early fibrinogen replacement are research imperatives,
and are likely to yield significant therapeutic benefit.
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